These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8034015)
1. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B. Champagne MJ; Lamontagne S; Potier M FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015 [TBL] [Abstract][Full Text] [Related]
2. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B. Champagne MJ; Lamontagne S; Potier M FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides. Lamontagne S; Potier M J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151 [TBL] [Abstract][Full Text] [Related]
4. The effect of carbohydrate removal on stability and activity of saposin B. Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782 [TBL] [Abstract][Full Text] [Related]
5. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders. Schmid B; Paton BC; Sandhoff K; Harzer K Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229 [TBL] [Abstract][Full Text] [Related]
6. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP. Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779 [TBL] [Abstract][Full Text] [Related]
7. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C. Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489 [TBL] [Abstract][Full Text] [Related]
10. Determination of saposin proteins (sphingolipid activator proteins) in human tissues. Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y Anal Biochem; 1990 Nov; 190(2):154-7. PubMed ID: 2127157 [TBL] [Abstract][Full Text] [Related]
11. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase. Weiler S; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM Protein Sci; 1995 Apr; 4(4):756-64. PubMed ID: 7613473 [TBL] [Abstract][Full Text] [Related]
12. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis. Zschoche A; Fürst W; Schwarzmann G; Sanhoff K Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356 [TBL] [Abstract][Full Text] [Related]
13. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide. Wynn CH Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882 [TBL] [Abstract][Full Text] [Related]
15. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348 [TBL] [Abstract][Full Text] [Related]
16. Expression and specificity of human GM2 activator protein. Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933 [TBL] [Abstract][Full Text] [Related]
17. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase. Qi X; Leonova T; Grabowski GA J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997 [TBL] [Abstract][Full Text] [Related]
18. Conformational and amino acid residue requirements for the saposin C neuritogenic effect. Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Ahn VE; Faull KF; Whitelegge JP; Fluharty AL; Privé GG Proc Natl Acad Sci U S A; 2003 Jan; 100(1):38-43. PubMed ID: 12518053 [TBL] [Abstract][Full Text] [Related]